Advertisement
Screener

REATA PHARMACEUTICALS INC Proceeds from Other Equity

REATA PHARMACEUTICALS INC Proceeds from Other Equity

REATA PHARMACEUTICALS INC reported Proceeds from Other Equity of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromOtherEquity · last filed 2020-05-11

  • REATA PHARMACEUTICALS INC proceeds from other equity for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • REATA PHARMACEUTICALS INC proceeds from other equity for the quarter ending 2019-12-31 was $0.00.
  • REATA PHARMACEUTICALS INC proceeds from other equity for the quarter ending 2019-09-30 was $0.00.
  • REATA PHARMACEUTICALS INC proceeds from other equity for the quarter ending 2019-06-30 was $0.00.
  • REATA PHARMACEUTICALS INC proceeds from other equity for fiscal 2019 was $107.00K, a 1237.50% increase from fiscal 2018.
  • REATA PHARMACEUTICALS INC proceeds from other equity for fiscal 2018 was $8.00K, a 60.00% increase from fiscal 2017.
  • REATA PHARMACEUTICALS INC proceeds from other equity for fiscal 2017 was $5.00K.
Period endProceeds from Other Equity 3 monthProceeds from Other Equity 6 monthProceeds from Other Equity 9 monthProceeds from Other Equity 12 month
2020-03-31$0.00
10-Q · filed 2020-05-11
$0.00
derived: sum of 2 quarters · filed 2020-05-11
$0.00
derived: sum of 3 quarters · filed 2020-05-11
$0.00
derived: sum of 4 quarters · filed 2020-05-11
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$0.00
derived: sum of 2 quarters · filed 2020-02-19
$0.00
derived: sum of 3 quarters · filed 2020-02-19
$107.00K
10-K · filed 2020-02-19
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$0.00
derived: sum of 2 quarters · filed 2019-11-12
$107.00K
10-Q · filed 2019-11-12
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$107.00K
10-Q · filed 2019-08-08
2019-03-31$107.00K
10-Q · filed 2020-05-11
2018-12-31$8.00K
10-K · filed 2020-02-19
2017-12-31$5.00K
10-K · filed 2020-02-19